Sunday, November 1, 2026

Horizon Therapeutics And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team

September 23, 2021

Horizon Therapeutics  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Horizon Therapeutics (HZNP), Dolby Laboratories (DLB), Sealed Air Corporation (SEE) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Horizon Therapeutics (HZNP)

27.5% sales growth and 9.27% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics's sales growth this year is anticipated to be 41.2% and 23.5% for next year.

Year-on-year quarterly revenue growth declined by 3.8%, now sitting on 2.19B for the twelve trailing months.

Volume

Today's last reported volume for Horizon Therapeutics is 1353460 which is 14.18% above its average volume of 1185290.

Horizon Therapeutics's sales growth for the next quarter is 27.5%. The company's growth estimates for the current quarter and the next is a negative 11.5% and 10.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.27%.

Volatility

Horizon Therapeutics's last day, last week, and last month's current volatility was 0.23%, 0.65%, and 0.81%, respectively.

Horizon Therapeutics's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.02% (day), 1.88% (last week), and 2.24% (last month), respectively.

Horizon Therapeutics's Stock Yearly Top and Bottom Value

Horizon Therapeutics's stock is valued at $109.96 at 01:22 EST, below its 52-week high of $111.70 and way above its 52-week low of $66.41.

Horizon Therapeutics's Moving Average

Horizon Therapeutics's worth is higher than its 50-day moving average of $107.01 and way higher than its 200-day moving average of $96.06.

2. Dolby Laboratories (DLB)

14.3% sales growth and 11.87% return on equity

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices.

Dolby Laboratories's sales growth this year is expected to be 11.6% and 7.8% for next year.

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 1.27B for the twelve trailing months.

Volume

Today's last reported volume for Dolby Laboratories is 322679 which is 6.85% below its average volume of 346431.

Dolby Laboratories's sales growth for the next quarter is 14.3%. The company's growth estimates for the ongoing quarter and the next is 26.7% and negative -10.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.87%.

Volatility

Dolby Laboratories's last day, last week, and last month's current volatility was 0.76%, 1.29%, and 0.90%, respectively.

Dolby Laboratories's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.61% (day), 1.98% (last week), and 1.63% (last month), respectively.

Dolby Laboratories's Stock Yearly Top and Bottom Value

Dolby Laboratories's stock is valued at $91.76 at 01:22 EST, way below its 52-week high of $104.74 and way above its 52-week low of $63.68.

Dolby Laboratories's Moving Average

Dolby Laboratories's worth is below its 50-day moving average of $97.24 and under its 200-day moving average of $98.31.

3. Sealed Air Corporation (SEE)

11% sales growth and 4081.86% return on equity

Sealed Air Corporation provides food safety and security, and product protection solutions and equipment in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific.

Sealed Air Corporation's sales growth this year is anticipated to be 11.4% and 3.5% for next year.

Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 5.17B for the twelve trailing months.

Volume

Today's last reported volume for Sealed Air Corporation is 1802110 which is 89.02% above its average volume of 953396.

Sealed Air Corporation's sales growth is a negative 0% for the current quarter and 11% for the next. The company's growth estimates for the ongoing quarter and the next is 1.2% and 28.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4081.86%.

Volatility

Sealed Air Corporation's last day, last week, and last month's current volatility was 2.81%, 0.95%, and 0.83%, respectively.

Sealed Air Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.30% (day), 1.84% (last week), and 1.56% (last month), respectively.

Sealed Air Corporation's Stock Yearly Top and Bottom Value

Sealed Air Corporation's stock is valued at $56.27 at 01:22 EST, under its 52-week high of $62.04 and way above its 52-week low of $36.27.

Sealed Air Corporation's Moving Average

Sealed Air Corporation's value is under its 50-day moving average of $59.37 and above its 200-day moving average of $54.35.

4. Progress Software Corporation (PRGS)

9.4% sales growth and 21.02% return on equity

Progress Software Corporation develops business applications.

Progress Software Corporation's sales growth this year is anticipated to be 16.9% and 2.6% for next year.

Year-on-year quarterly revenue growth grew by 22%, now sitting on 475.85M for the twelve trailing months.

Volume

Today's last reported volume for Progress Software Corporation is 830105 which is 199.53% above its average volume of 277130.

Progress Software Corporation's sales growth is a negative 0% for the present quarter and 9.4% for the next. The company's growth estimates for the current quarter and the next is 5.1% and negative -5.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.02%.

Volatility

Progress Software Corporation's last day, last week, and last month's current volatility was 1.95%, 0.80%, and 1.05%, respectively.

Progress Software Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.60% (day), 2.01% (last week), and 1.76% (last month), respectively.

Progress Software Corporation's Stock Yearly Top and Bottom Value

Progress Software Corporation's stock is valued at $46.09 at 01:22 EST, below its 52-week high of $49.23 and way above its 52-week low of $34.40.

Progress Software Corporation's Moving Average

Progress Software Corporation's worth is above its 50-day moving average of $45.65 and higher than its 200-day moving average of $45.24.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Goes Operational: Platform Governance, Local Silicon, and the Physical-AI Data Race
In mid-to-late October 2026, enterprise vendors (Cisco, Fortinet, ServiceNow, Intuit, Salesforce/Braze, Adobe) shipped agent governance, AI security and AI-driven customer engagement products, while a parallel hardware wave (NVIDIA RTX Spark laptops, ASUS, Apple's iPad mini, Microsoft's hybrid local/cloud Windows) pushed AI onto local devices. A third strand, physical AI (Encord, Harvest Praxis, Hesai), argues that real-world sensor data and cheaper edge chips are the next bottleneck. The common thread is the shift from AI experimentation to governed, scaled deployment, with Salesforce's Braze acquisition showing consolidation and fintech players like Intuit tying AI to trusted financial data. The facts support a broad industry theme but contain little direct finance or regulatory evidence, so the AI-finance angle is thin.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,532 source documents archived
Query this data → isubstrate.com